Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China
· Delayed Price · Currency is CNY 5.28
+0.09 (1.73%)
May 23, 2025, 2:45 PM CST
SHE:000597 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 7,455 | 7,448 | 8,185 | 8,719 | 8,046 | 7,300 | Upgrade
|
| Other Revenue | 54.09 | 54.09 | 58.56 | 89.5 | 98.7 | 84.31 | Upgrade
|
| Revenue | 7,510 | 7,503 | 8,243 | 8,809 | 8,145 | 7,384 | Upgrade
|
| Revenue Growth (YoY) | -4.08% | -8.98% | -6.42% | 8.15% | 10.30% | -10.17% | Upgrade
|
| Cost of Revenue | 4,825 | 4,741 | 5,125 | 5,557 | 5,056 | 4,596 | Upgrade
|
| Gross Profit | 2,685 | 2,761 | 3,118 | 3,252 | 3,089 | 2,789 | Upgrade
|
| Selling, General & Admin | 2,008 | 2,096 | 2,579 | 2,767 | 2,698 | 2,452 | Upgrade
|
| Research & Development | 132.73 | 117.76 | 97.04 | 160.39 | 83.46 | 74.18 | Upgrade
|
| Other Operating Expenses | 108.63 | 77.34 | 81.75 | 83.13 | 83.86 | 48.04 | Upgrade
|
| Operating Expenses | 2,250 | 2,285 | 2,752 | 3,032 | 2,879 | 2,575 | Upgrade
|
| Operating Income | 434.46 | 475.95 | 366.2 | 219.56 | 210.63 | 213.53 | Upgrade
|
| Interest Expense | -58.36 | -64.53 | -78.36 | -92.11 | -120.16 | -120.87 | Upgrade
|
| Interest & Investment Income | 131.71 | 133.79 | 163.69 | 93.88 | 110.25 | 58.43 | Upgrade
|
| Currency Exchange Gain (Loss) | 10.06 | 10.06 | 8.11 | 28.68 | -6.45 | -18.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -51.09 | -49.15 | -54.94 | -37.85 | -47.68 | -22.04 | Upgrade
|
| EBT Excluding Unusual Items | 466.77 | 506.12 | 404.7 | 212.15 | 146.59 | 111.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.19 | 6.19 | 0.17 | 419.3 | 3.29 | 12.29 | Upgrade
|
| Asset Writedown | -36.89 | -10.12 | -3.9 | -7.97 | -28.96 | -23.17 | Upgrade
|
| Other Unusual Items | 107.48 | 91.72 | 87.21 | -98.04 | -0.76 | -8.32 | Upgrade
|
| Pretax Income | 543.55 | 593.91 | 488.17 | 525.44 | 120.16 | 91.84 | Upgrade
|
| Income Tax Expense | 144.68 | 170.63 | 112.19 | 168.28 | 24.72 | 81.01 | Upgrade
|
| Earnings From Continuing Operations | 398.87 | 423.28 | 375.98 | 357.16 | 95.44 | 10.83 | Upgrade
|
| Minority Interest in Earnings | -10.34 | -13.43 | -17.52 | -6.9 | 3.59 | 1.43 | Upgrade
|
| Net Income | 388.54 | 409.85 | 358.46 | 350.25 | 99.03 | 12.26 | Upgrade
|
| Net Income to Common | 388.54 | 409.85 | 358.46 | 350.25 | 99.03 | 12.26 | Upgrade
|
| Net Income Growth | 12.28% | 14.34% | 2.34% | 253.69% | 707.93% | -92.95% | Upgrade
|
| Shares Outstanding (Basic) | 1,416 | 1,413 | 1,434 | 1,401 | 1,415 | 1,226 | Upgrade
|
| Shares Outstanding (Diluted) | 1,416 | 1,413 | 1,434 | 1,401 | 1,415 | 1,226 | Upgrade
|
| Shares Change (YoY) | -1.42% | -1.43% | 2.34% | -0.97% | 15.42% | -8.41% | Upgrade
|
| EPS (Basic) | 0.27 | 0.29 | 0.25 | 0.25 | 0.07 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.27 | 0.29 | 0.25 | 0.25 | 0.07 | 0.01 | Upgrade
|
| EPS Growth | 13.89% | 16.00% | - | 257.14% | 600.00% | -92.31% | Upgrade
|
| Free Cash Flow | 497.03 | 599.34 | 351.32 | 864.44 | 626.7 | 170.54 | Upgrade
|
| Free Cash Flow Per Share | 0.35 | 0.42 | 0.24 | 0.62 | 0.44 | 0.14 | Upgrade
|
| Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.100 | 0.014 | 0.008 | Upgrade
|
| Dividend Growth | - | - | - | 614.29% | 75.00% | - | Upgrade
|
| Gross Margin | 35.75% | 36.81% | 37.83% | 36.92% | 37.93% | 37.76% | Upgrade
|
| Operating Margin | 5.79% | 6.34% | 4.44% | 2.49% | 2.59% | 2.89% | Upgrade
|
| Profit Margin | 5.17% | 5.46% | 4.35% | 3.98% | 1.22% | 0.17% | Upgrade
|
| Free Cash Flow Margin | 6.62% | 7.99% | 4.26% | 9.81% | 7.69% | 2.31% | Upgrade
|
| EBITDA | 976.55 | 1,019 | 911.39 | 754.38 | 722.45 | 694.29 | Upgrade
|
| EBITDA Margin | 13.00% | 13.58% | 11.06% | 8.56% | 8.87% | 9.40% | Upgrade
|
| D&A For EBITDA | 542.09 | 542.71 | 545.19 | 534.82 | 511.82 | 480.76 | Upgrade
|
| EBIT | 434.46 | 475.95 | 366.2 | 219.56 | 210.63 | 213.53 | Upgrade
|
| EBIT Margin | 5.79% | 6.34% | 4.44% | 2.49% | 2.59% | 2.89% | Upgrade
|
| Effective Tax Rate | 26.62% | 28.73% | 22.98% | 32.03% | 20.57% | 88.21% | Upgrade
|
| Revenue as Reported | 7,510 | 7,503 | 8,243 | 8,809 | 8,145 | 7,384 | Upgrade
|
| Advertising Expenses | - | - | - | 7.13 | 10.53 | 3.35 | Upgrade
|
Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.